Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) became a publicly traded company in 2021 through its business combination with DFB Healthcare Acquisitions Corp., a healthcare-focused blank-check vehicle that completed its initial public offering in 2020. The SPAC was sponsored by DFB Healthcare Acquisitions, LLC, a healthcare-oriented sponsor group. Following the close of the de-SPAC transaction, the combined company filed a Form 10-Q/A with the Securities and Exchange Commission on December 14, 2021, representing an amendment to a previously submitted quarterly report. TOI operates in the oncology and specialty healthcare sector, providing community-based cancer care services across the United States. Sign up at SpacDesk for complete filing histories, sponsor profiles, and deal data on TOI and every other SPAC transaction in our database.